Tempest Therapeutics Inc
(TPST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 7,581 | 8,934 | 8,771 | 8,774 | 8,161 |
| Operating Income | -7,581 | -8,934 | -8,771 | -8,774 | -8,161 |
| Interest Expense | 344 | 432 | 389 | 464 | 333 |
| Other Income | 289 | 263 | 213 | 70 | 3 |
| Pre-tax Income | -7,636 | -9,103 | -8,947 | -9,168 | -8,491 |
| Net Income Continuous | -7,636 | -9,103 | -8,947 | -9,168 | -8,491 |
| Net Income | $-7,636 | $-9,103 | $-8,947 | $-9,168 | $-8,491 |
| EPS Basic Total Ops | -7.15 | -5.98 | -8.58 | -10.27 | -15.34 |
| EPS Basic Continuous Ops | -7.21 | -5.97 | -8.53 | -10.30 | -15.41 |
| EPS Diluted Total Ops | -7.15 | -5.98 | -8.58 | -10.27 | -15.34 |
| EPS Diluted Continuous Ops | -7.21 | -5.97 | -8.53 | -10.30 | -15.41 |
| EBITDA(a) | $-7,456 | $-8,717 | $-8,570 | $-8,662 | $-8,053 |